Patents Assigned to Photoprotective Technologies Incorporated
-
Publication number: 20230255828Abstract: The detailed characteristics of the red fluorescence of the human lens—that occurs at the seventh decade of life—is recognized as an example of evolutionary photobiomodulation for repair of the retina, and then used as a paradigm for extending current parametric values for reproducible photobiomodulation. The new photobiomodulation parameters involve relative intensities for wavelength bands within the range of 600 nm to 900 nm.Type: ApplicationFiled: April 19, 2023Publication date: August 17, 2023Applicant: Photoprotective Technologies IncorporatedInventor: James M. Gallas
-
Publication number: 20200323686Abstract: The detailed characteristics of the red fluorescence of the human lens—that occurs at the seventh decade of life—is recognized as an example of evolutionary photobiomodulation for repair of the retina, and then used as a paradigm for extending current parametric values for reproducible photobiomodulation. The new photobiomodulation parameters involve relative intensities for wavelength bands within the range of 600 nm to 900 nm.Type: ApplicationFiled: April 13, 2020Publication date: October 15, 2020Applicant: Photoprotective Technologies IncorporatedInventor: James M. Gallas
-
Publication number: 20200133027Abstract: According to the present invention, light filters are disclosed that provide photoprotection and contain fluorescent agents in that have fluorescence emission in the near infrared region of wavelengths to effect photobiological modulation (PBM) of human cells when the cells are exposed to sunlight or any artificial lighting. The fluorescent agents include endogenous compounds. The light filters include ophthalmic lenses, skin care products with or without transparent substrate and any products that are used to filter light. When used in connection with ophthalmic lenses, the ophthalmic lense provides photoprotection and photobiological modulation to the human eye.Type: ApplicationFiled: January 30, 2018Publication date: April 30, 2020Applicant: Photoprotective Technologies IncorporatedInventors: James M. Gallas, Matthew T. Gordon
-
Publication number: 20190374789Abstract: An ophthalmic lens comprising a clear, non-tinted, solid plastic substrate and a dye suitable for undergoing fluorescence upconversion wherein said dye absorbs light in the near infrared region from 850 nm to 2500 nm and emit light in the shorter wavelength region from 650 nm to 850 nm thereby providing photobiomodulation to the eye.Type: ApplicationFiled: June 11, 2019Publication date: December 12, 2019Applicant: Photoprotective Technologies IncorporatedInventor: James M. Gallas
-
Publication number: 20190212582Abstract: A method that uses the transmission spectrum of an opthalmic lens to generate, as output, the ratio of the average transmission of sunlight that repairs the retina to the average transmission of sunlight that causes damage to the retina. This ratio is compared with a similar ratio for the naked eye that correlates with macular degeneration and allows the user to select a ratio that extends the risk of acquiring macular degeneration by multiples of an average lifetime.Type: ApplicationFiled: January 10, 2019Publication date: July 11, 2019Applicant: Photoprotective Technologies incorporatedInventor: James Martin Gallas
-
Publication number: 20180024383Abstract: According to the present invention, light filters are disclosed that provide photoprotection and contain fluorescent agents that have fluorescence emission in the near infrared region of wavelengths to effect photobiological modulation (PBM) of human cells when the cells are exposed to sunlight or any artificial lighting. The fluorescent agents include endogenous compounds. The light filters include ophthalmic lenses, skin care products with or without transparent substrate and any products that are used to filter light. When used in connection with ophthalmic lenses, the ophthalmic lense provides photoprotection and photobiological modulation to the human eye.Type: ApplicationFiled: June 27, 2017Publication date: January 25, 2018Applicant: Photoprotective Technologies IncorporatedInventors: James M. Gallas, Matthew T. Gordon
-
Publication number: 20170299897Abstract: Ophthalmic lenses and light filters containing special additives that have fluorescence emission in the near infrared region of wavelengths—in order to enhance phototherapy for the human eye when it is exposed to sunlight and artificial lighting.Type: ApplicationFiled: June 29, 2017Publication date: October 19, 2017Applicant: Photoprotective Technologies IncorporatedInventor: James M. Gallas
-
Patent number: 9726910Abstract: Ophthalmic lenses and light filters containing special additives that have fluorescence emission in the near infrared region of wavelengths—in order to enhance phototherapy for the human eye when it is exposed to sunlight and artificial lighting.Type: GrantFiled: July 14, 2014Date of Patent: August 8, 2017Assignee: PHOTOPROTECTIVE TECHNOLOGIES INCORPORATEDInventor: James Martin Gallas
-
Patent number: 5116884Abstract: A hydrophilic contact lens is disclosed incorporating melanin that protects the eye from harmful radiation and superoxide.Type: GrantFiled: February 16, 1990Date of Patent: May 26, 1992Assignee: Photoprotective Technology IncorporatedInventor: James M. Gallas
-
Patent number: 5112883Abstract: The present invention is directed to a medium incorporating melanin for radiation protection.Type: GrantFiled: November 9, 1990Date of Patent: May 12, 1992Assignee: Photoprotective Technologies IncorporatedInventor: James M. Gallas